Pro-malignant properties of STAT3 during chronic inflammation.
作者信息
Demaria Marco, Poli Valeria
出版信息
Oncotarget. 2012 Apr;3(4):359-60. doi: 10.18632/oncotarget.482.
Abstract
摘要
相似文献
1
Pro-malignant properties of STAT3 during chronic inflammation.
Oncotarget. 2012 Apr;3(4):359-60. doi: 10.18632/oncotarget.482.
2
TWEAK/Fn14 promotes pro-inflammatory cytokine secretion in hepatic stellate cells via NF-κB/STAT3 pathways.
Mol Immunol. 2017 Jul;87:67-75. doi: 10.1016/j.molimm.2017.04.003. Epub 2017 Apr 12.
3
STAT3 activation of miR-21 and miR-181b-1 via PTEN and CYLD are part of the epigenetic switch linking inflammation to cancer.
Mol Cell. 2010 Aug 27;39(4):493-506. doi: 10.1016/j.molcel.2010.07.023.
4
IKK/NF-kappaB and STAT3 pathways: central signalling hubs in inflammation-mediated tumour promotion and metastasis.
EMBO Rep. 2009 Dec;10(12):1314-9. doi: 10.1038/embor.2009.243. Epub 2009 Nov 6.
5
Inflammation and gastrointestinal cancer: an overview.
Cancer Lett. 2014 Apr 10;345(2):153-6. doi: 10.1016/j.canlet.2013.08.025. Epub 2013 Aug 24.
6
IL6-mediated suppression of miR-200c directs constitutive activation of inflammatory signaling circuit driving transformation and tumorigenesis.
Mol Cell. 2012 Mar 30;45(6):777-89. doi: 10.1016/j.molcel.2012.01.015. Epub 2012 Feb 23.
7
Activation of the B-cell receptor successively activates NF-κB and STAT3 in chronic lymphocytic leukemia cells.
Int J Cancer. 2017 Nov 15;141(10):2076-2081. doi: 10.1002/ijc.30892. Epub 2017 Aug 4.
8
Targeting the inflammatory pathways to enhance chemotherapy of cancer.
Cancer Biol Ther. 2011 Jul 15;12(2):95-105. doi: 10.4161/cbt.12.2.15952.
9
Inflammation, cytokines, the IL-17/IL-6/STAT3/NF-κB axis, and tumorigenesis.
Drug Des Devel Ther. 2015 Jun 8;9:2941-6. doi: 10.2147/DDDT.S86396. eCollection 2015.
10
Tumor necrosis factor α-induced proteins: natural brakes on inflammation.
Arthritis Rheum. 2012 Dec;64(12):3831-4. doi: 10.1002/art.34664.
引用本文的文献
1
The role of IL-22 in cancer.
Med Oncol. 2024 Sep 5;41(10):240. doi: 10.1007/s12032-024-02481-8.
2
IL-27 mediates HLA class I up-regulation, which can be inhibited by the IL-6 pathway, in HLA-deficient Small Cell Lung Cancer cells.
J Exp Clin Cancer Res. 2017 Oct 11;36(1):140. doi: 10.1186/s13046-017-0608-z.
3
Endothelial fibrosis induced by suppressed STAT3 expression mediated by signaling involving the TGF-β1/ALK5/Smad pathway.
Lab Invest. 2017 Sep;97(9):1033-1046. doi: 10.1038/labinvest.2017.61. Epub 2017 Jul 24.
4
Oncogenic transformation of human lung bronchial epithelial cells induced by arsenic involves ROS-dependent activation of STAT3-miR-21-PDCD4 mechanism.
Sci Rep. 2016 Nov 23;6:37227. doi: 10.1038/srep37227.
5
Transcriptional repression of SOCS3 mediated by IL-6/STAT3 signaling via DNMT1 promotes pancreatic cancer growth and metastasis.
J Exp Clin Cancer Res. 2016 Feb 4;35:27. doi: 10.1186/s13046-016-0301-7.
6
STAT3 blockade enhances the efficacy of conventional chemotherapeutic agents by eradicating head neck stemloid cancer cell.
Oncotarget. 2015 Dec 8;6(39):41944-58. doi: 10.18632/oncotarget.5986.
7
Oncostatin M binds to extracellular matrix in a bioactive conformation: implications for inflammation and metastasis.
Cytokine. 2015 Mar;72(1):71-85. doi: 10.1016/j.cyto.2014.11.007. Epub 2015 Jan 23.
8
Activation of miR-21 by STAT3 induces proliferation and suppresses apoptosis in nasopharyngeal carcinoma by targeting PTEN gene.
PLoS One. 2014 Nov 3;9(11):e109929. doi: 10.1371/journal.pone.0109929. eCollection 2014.
9
IL-6-stimulated CD11b+ CD14+ HLA-DR- myeloid-derived suppressor cells, are associated with progression and poor prognosis in squamous cell carcinoma of the esophagus.
Oncotarget. 2014 Sep 30;5(18):8716-28. doi: 10.18632/oncotarget.2368.
10
SIAH2 antagonizes TYK2-STAT3 signaling in lung carcinoma cells.
Oncotarget. 2014 May 30;5(10):3184-96. doi: 10.18632/oncotarget.1899.
本文引用的文献
1
STAT3 can serve as a hit in the process of malignant transformation of primary cells.
Cell Death Differ. 2012 Aug;19(8):1390-7. doi: 10.1038/cdd.2012.20. Epub 2012 Mar 9.
2
The unholy trinity: inflammation, cytokines, and STAT3 shape the cancer microenvironment.
Cancer Cell. 2011 Apr 12;19(4):429-31. doi: 10.1016/j.ccr.2011.03.018.
3
A STAT3-mediated metabolic switch is involved in tumour transformation and STAT3 addiction.
Aging (Albany NY). 2010 Nov;2(11):823-42. doi: 10.18632/aging.100232.
4
Constitutively active Stat3 enhances neu-mediated migration and metastasis in mammary tumors via upregulation of Cten.
Cancer Res. 2010 Mar 15;70(6):2558-67. doi: 10.1158/0008-5472.CAN-09-2840. Epub 2010 Mar 9.
5
STAT3 as a target for inducing apoptosis in solid and hematological tumors.
Cell Res. 2008 Feb;18(2):254-67. doi: 10.1038/cr.2008.18.
6
IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer.
Cell. 2004 Aug 6;118(3):285-96. doi: 10.1016/j.cell.2004.07.013.
7
Nuclear transcription factor-kappaB as a target for cancer drug development.
Leukemia. 2002 Jun;16(6):1053-68. doi: 10.1038/sj.leu.2402482.
8
Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty.
Annu Rev Med. 2000;51:245-70. doi: 10.1146/annurev.med.51.1.245.
9
The causes and prevention of cancer.
Proc Natl Acad Sci U S A. 1995 Jun 6;92(12):5258-65. doi: 10.1073/pnas.92.12.5258.
Zotero 插件